Figures and Tables
From the following article:
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Jerry M. Wells & Annick Mercenier
Nature Reviews Microbiology 6, 349-362 (May 2008)
doi:10.1038/nrmicro1840
Figure 1
Fate of recombinant lactic acid bacteria in the intestinal tract.
Figure 2
Anti-infective strategies based on mucosal delivery of single-chain variable fragment antibodies.
Figure 3
Delivery of anti-infectives for HIV-1.
Figure 4
Current applications of lactic acid bacteria (LAB) delivery.
Table 1
Protection studies with lactic acid bacteria vaccines
